ClinicalMetric / Countries / Austria / interstitial lung diseases
← 🇦🇹 Austria Trials
🇦🇹 Austria Country × Condition

interstitial lung diseases Clinical Trials in Austria

Active clinical trials for interstitial lung diseases with research sites in Austria. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 1 // Recruiting: 1 Phases: Phase 3 // Updated: Daily
Total Trials
1
Recruiting Now
1
Country
🇦🇹 Austria

Active Trials in Austria (1)

NCT06806592 Phase 3
Recruiting

A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases

Enrollment
400 pts
Country
🇦🇹 Austria
Boehringer Ingelheim
View Trial →

Frequently Asked Questions

How many interstitial lung diseases clinical trials are active in Austria?
There are currently 1 active clinical trials for interstitial lung diseases with sites in Austria, of which 1 are actively recruiting patients.
How can I join a interstitial lung diseases clinical trial in Austria?
To join a interstitial lung diseases clinical trial in Austria, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Austria directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are interstitial lung diseases trials in Austria?
Active interstitial lung diseases trials in Austria span Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Austria Trials → Global interstitial lung diseases Trials → All Countries → All Trials →